Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

904
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
904
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

319
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
319
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

458
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
458
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

363
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
363
Inflammation01:38

Inflammation

61.6K
Overview
61.6K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

366
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
366

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The novel GLP-1/GIP dual receptor agonist DA5-CH is superior to tirzepatide and exendin-4 in the 6-OHDA Parkinson rat model.

Frontiers in endocrinology·2026
Same author

LELN: A Large Language Model-Dynamically Enhanced Learning Network for Patient Similarity Calculation.

IEEE journal of biomedical and health informatics·2026
Same author

A paradigm-level evaluation of deep learning architectures for plant pest and disease recognition under data-scarce field conditions.

Frontiers in plant science·2026
Same author

Metabolic reprogramming in aortic diseases: insights from metabolomics and therapeutic opportunities.

Medical review (2021)·2026
Same author

Promoting Electroreduction of Nitrate to Ammonia in Neutral Media via the Synergistic Effect of Atomically Dispersed Fe, Cu, and Pd Sites.

Small (Weinheim an der Bergstrasse, Germany)·2026
Same author

Extreme rainfall and anaemia among children under five in 46 low- and middle-income countries.

BMJ global health·2026

Related Experiment Video

Updated: Jan 15, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.7K

SWAP70 Promotes Atherosclerosis Via Endothelial CAV1 Nuclear Translocation.

Tianyu Gao1,2, Xinxin Li1,2, Wei Zhang1,2

  • 1School of Public Health and Emergency Management, School of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China (T.G., X.L., W.Z., Y.Y., Y.L., F.L., B.B., D.G.).

Circulation Research
|January 14, 2026
PubMed
Summary
This summary is machine-generated.

Switch-associated protein 70 (SWAP70) regulates endothelial inflammation and atherosclerosis by facilitating caveolin-1 nuclear translocation. Targeting this pathway offers a novel therapeutic strategy for cardiovascular disease.

Keywords:
SWAP70 protein, humanatherosclerosiscaveolin 1endothelial cellshemodynamicsinflammation

More Related Videos

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.9K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.5K

Related Experiment Videos

Last Updated: Jan 15, 2026

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.7K
Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice
07:51

Implantation of a Carotid Cuff for Triggering Shear-stress Induced Atherosclerosis in Mice

Published on: January 13, 2012

20.9K
Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
07:36

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice

Published on: September 26, 2018

10.5K

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Endothelial Cell Biology

Background:

  • Atherosclerosis, a primary cause of coronary artery disease, stems from disturbed blood flow and chronic endothelial inflammation.
  • Switch-associated protein 70 (SWAP70) is genetically linked to coronary artery disease but its role in atherogenesis is unclear.

Purpose of the Study:

  • To investigate the functional role of SWAP70 in vascular inflammation and atherosclerotic plaque development.
  • To elucidate the molecular mechanisms by which SWAP70 influences endothelial responses to mechanical stress and inflammation.

Main Methods:

  • Utilized endothelial cell-specific Swap70 overexpression and knockout mouse models.
  • Employed lentiviral overexpression and siRNA knockdown in human umbilical vein endothelial cells.
  • Conducted in vitro assays under oscillatory shear stress and cytokine stimulation, alongside mechanistic studies including co-immunoprecipitation and RNA sequencing.

Main Results:

  • SWAP70 expression increased under oscillatory shear stress and in human atherosclerotic plaques.
  • SWAP70 facilitated caveolin-1 nuclear translocation, enhancing inflammatory gene expression.
  • Endothelial-specific Swap70 deletion attenuated atherosclerosis in vivo, while overexpression exacerbated inflammation.

Conclusions:

  • SWAP70 acts as a mechano-responsive regulator of endothelial inflammation and atherosclerosis via a novel SWAP70-CAV1 signaling axis.
  • Targeting the SWAP70-CAV1 interaction presents a potential therapeutic strategy for atherosclerotic cardiovascular disease.